BioHealth Analyst Cautious/Negative Calls (BIIB, ESRX, GENZ, MHS, SGEN)

June 19, 2008 · Filed Under General 

These are some of the downgrades and negative or cautious calls being seen in the biotech and medical-health sectors this Thursday morning:

  • Biogen-IDEC (NASDAQ: BIIB) Started as Hold at Deutsche Bank.
  • Express Scripts (NASDAQ: ESRX) Cut to Neutral from Buy at UBS.
  • Genzyme (NASDAQ: GENZ) Started As Hold at Deutsche Bank.
  • Medco Health Solutions (NYSE: MHS) cut to Neutral at UBS.
  • Seattle Genetics (NASDAQ: SGEN) Started as Neutral at UBS.

You can see the list of positive calls and upgrades here.

Jon Ogg
June 19, 2008


Comments are closed.

    Subscribe to BioHealth Investor BioHealth Investor RSS Feed